02:19:13 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande


2025-02-14 Bokslutskommuniké 2024
2024-11-14 Kvartalsrapport 2024-Q3
2024-08-16 Kvartalsrapport 2024-Q2
2024-05-30 Årsstämma 2024
2024-05-17 Kvartalsrapport 2024-Q1
2024-03-01 X-dag ordinarie utdelning CSMED 0.00 DKK
2024-02-14 Bokslutskommuniké 2023
2023-12-15 X-dag ordinarie utdelning CSMED 0.00 DKK
2023-07-18 Kvartalsrapport 2023-Q3
2023-05-17 Kvartalsrapport 2023-Q2
2023-04-14 Extra Bolagsstämma 2023
2023-02-17 Kvartalsrapport 2023-Q1
2023-02-14 Årsstämma 2023
2023-02-10 X-dag ordinarie utdelning CSMED 0.00 DKK
2022-11-18 Bokslutskommuniké 2022
2022-08-13 Kvartalsrapport 2022-Q3
2022-05-20 Kvartalsrapport 2022-Q2
2022-02-18 Kvartalsrapport 2022-Q1
2021-12-10 X-dag ordinarie utdelning CSMED 0.00 DKK
2021-12-09 Årsstämma 2022
2021-11-18 Bokslutskommuniké 2021


ListaSpotlight DK
IndustriLäkemedel & Handel
CS Medica är ett danskt medicintekniskt bolag, dedikerat till läkemedelsforskning, utveckling, tillverkning och global kommersialisering. Bolaget blandar vetenskap och natur för att förbättra patienters liv med cannabinoidterapier för smärtlindring, och för att hantera autoimmuna och stressrelaterade symtom. Globalt erbjuder CS Medica CBD-behandlingar över disk (OTC), inklusive patenterade medicinska produkter, MHRA och MDR-registrerade artiklar, under varumärket CANNASEN® eller med egen märkning.
2023-06-14 17:13:31

The shareholders of CS MEDICA A/S ("CS MEDICA" or the "Company") are hereby notified of an Extraordinary General Meeting that will be held on Friday the 30[th] of June 2023 at 15:00 at TEAMS. Shareholders will be entitled to vote by submitting postal vote forms prior to the meeting. Information about the resolutions passed at the meeting will be made public after the extraordinary general meeting has been held.

CS MEDICA is convening an Extraordinary General Meeting (EGM) to address changes within the company's board.

Proposed agenda
1. Election of chairman of the meeting
2. Approval of new Board Member
3. Any other business.

--- o ---

Background Information for Approval of New Board Member
As part of the board's evaluation and adaptation process to tackle emerging challenges, Alexandre Fevre will be stepping down, while Karsten Adelmark will assume a position on the board to address the changes within the company's board. 

Karsten Adelmark's appointment aims to bolster CS MEDICA's growth plans with strong financial and business expertise and experience, among others board experience, strong IT track record, and value-based leadership.

Current and former positions of Karsten Adelmark:

Wolmer Gruppen
  • Chairman of the Board
  • MD and member of the board
Cybercom Consulting
  • CFO & Sales, MD and member of the board
  • CFO and member of the board
  • CFO and member of the board
Ernst & Young
  • Accountant and Team manager

The EGM marks an important step in CS MEDICA's commitment to evolving and strengthening its Board and leadership to better navigate the ever-changing healthcare landscape.

The company extends its appreciation to Alex for his valuable contributions and wishes him success in his future endeavors.

--- o ---

Registration for the EGM
The registration date is the 23rd of June 2023. Only those who are shareholders on this date can participate and vote at the extraordinary general meeting.

To obtain access to the general meeting and thus be able to participate and vote at the general meeting, a shareholder must, no later than 2 days before the general meeting, request an admission card, cf. section 5.9 of the articles of association. Such a request must be made to Sanne Holte, e-mail sh@cs-medica.com.The request must be received no later than the 23th of June 2023, at 11.59 PM (CET). A shareholder also has the possibility of requesting an admission card for a proxy holder who attends the general meeting by meeting on behalf of the shareholder. The request must be made according to the same above guidelines. The shareholder must fill in and sign the proxy and postal voting form, enclosed as schedule 1 which can also be found on the Company's website www.cs-medica.com. The proxy must bring the admission card and the original form to the general meeting.

The total number of votes as of the date of this notice is 12,322,635.  The board has already received 9.143.701 positive votes, corresponding to 74 %.

To be entitled to participate in the general meeting, shareholders whose shares are registered in the name of a nominee must temporarily re-register their shares in their own names in the share register. Such registration must be duly affected in the share register on the 23rd of June 2023 and the shareholders must therefore advise their nominees well in advance of such date.

The shareholders have the right to ask questions in relation to the issues on the agenda to be discussed at the general meeting. The questions can be made in writing before the general meeting or at the general meeting. The answer will - with the limitations that follow from the legislation - if possible be made at the general meeting or made available to the shareholders no later than two weeks after the general meeting.

All material mentioned in this notice can be obtained from Sanne Holte, e-mail sh@cs-medica.com.The material will only be forwarded by e-mail, and thus the e-mail address must be specified.

EGM - Date and time
June 30, 2023, from 15:00-16:00 p.m. CET

Registration for EGM  sh@cs-medica.com.

Power of Attorney
Schedule 1  >> (https://www.cs-medica.com/wp-content/uploads/2023/06/23-06-30-Schedule-1-POWER-OF-ATTORNEY.pdf)

On behalf of the board of directors
Jørgen Flemming Ladefoged, Chairman